Journal articles on the topic 'Bone inhibition'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Bone inhibition.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Ransjö, Maria, and Ulf H. Lerner. "Calcitonin causes a sustained inhibition of protein kinase C-stimulated bone resorption in contrast to the transient inhibition of parathyroid hormone-induced bone resorption." Acta Endocrinologica 123, no. 3 (September 1990): 251–56. http://dx.doi.org/10.1530/acta.0.1230251.
Full textZhou, Jiabao, Jennifer M. Down, Christopher N. George, Jessica Murphy, Diane V. Lefley, Claudia Tulotta, Marwa A. Alsharif, Michael Leach, and Penelope D. Ottewell. "Novel Methods of Targeting IL-1 Signalling for the Treatment of Breast Cancer Bone Metastasis." Cancers 14, no. 19 (October 1, 2022): 4816. http://dx.doi.org/10.3390/cancers14194816.
Full textDeng, Jianhua, Jun Wu, and Yuchang Zhu. "Inhibition of MicroRNA-9 Improves Fracture Healing by Modulating the Bone Morphogenetic Protein-7 Pathway." Pharmacology 104, no. 5-6 (2019): 352–58. http://dx.doi.org/10.1159/000502402.
Full textBanu, Jameela, Erika Varela, Ali N. Bahadur, Raheela Soomro, Nishu Kazi, and Gabriel Fernandes. "Inhibition of Bone Loss byCissus quadrangularisin Mice: A Preliminary Report." Journal of Osteoporosis 2012 (2012): 1–10. http://dx.doi.org/10.1155/2012/101206.
Full textVallet, Sonia, Kishan Patel, Nileshwari Vaghela, Mariateresa Fulciniti, Petter Veiby, Teru Hideshima, Samantha Pozzi, et al. "CCL3 Impairs Osteoblast Function Via Downregulation of Osteocalcin." Blood 114, no. 22 (November 20, 2009): 739. http://dx.doi.org/10.1182/blood.v114.22.739.739.
Full textWada, Teiji. "RANKL inhibition in bone metastases." Folia Pharmacologica Japonica 141, no. 1 (2013): 22–26. http://dx.doi.org/10.1254/fpj.141.22.
Full textTakayanagi, Hiroshi. "RANKL inhibition -Bone and beyond-." Proceedings for Annual Meeting of The Japanese Pharmacological Society WCP2018 (2018): SY42–1. http://dx.doi.org/10.1254/jpssuppl.wcp2018.0_sy42-1.
Full textMomenzadeh, Mahnaz, Maryam Khosravian, and Bhaskar VKS Lakkakula. "Potential of renin-angiotensin system inhibition to improve metabolic bone disorders." Journal of Nephropharmacology 10, no. 2 (October 17, 2020): e16-e16. http://dx.doi.org/10.34172/npj.2021.16.
Full textFraser, Christopher C., Kumiko Nagashima, Vito Sasseville, Jim Deeds, Alice McDonald, Chris Simpson, and Yajun Xu. "Selective Rapid B-Cell Depletion In Vivo by Pharmacologic IKK2 Inhibition." Blood 104, no. 11 (November 16, 2004): 2481. http://dx.doi.org/10.1182/blood.v104.11.2481.2481.
Full textKaipatur, N. R., M. Murshed, and M. D. McKee. "Matrix Gla Protein Inhibition of Tooth Mineralization." Journal of Dental Research 87, no. 9 (September 2008): 839–44. http://dx.doi.org/10.1177/154405910808700907.
Full textNakayama, Takayuki, Noriko Mutsuga, and Giovanna Tosato. "FGF2 posttranscriptionally down-regulates expression of SDF1 in bone marrow stromal cells through FGFR1 IIIc." Blood 109, no. 4 (October 31, 2006): 1363–72. http://dx.doi.org/10.1182/blood-2006-06-028217.
Full textMamedova, Elizaveta O., Tatiana A. Grebennikova, Zhanna E. Belaya, and Liudmila Y. Rozhinskaya. "Sclerostin antibodies as novel anabolic therapy for osteoporosis." Osteoporosis and Bone Diseases 21, no. 3 (April 8, 2019): 21–29. http://dx.doi.org/10.14341/osteo10127.
Full textOdes-Barth, Shlomit, Marina Khanin, Karin Linnewiel-Hermoni, Yifat Miller, Karina Abramov, Joseph Levy, and Yoav Sharoni. "Inhibition of Osteoclast Differentiation by Carotenoid Derivatives through Inhibition of the NF-κB Pathway." Antioxidants 9, no. 11 (November 23, 2020): 1167. http://dx.doi.org/10.3390/antiox9111167.
Full text&NA;. "Imatinib: hypophosphataemia and bone remodelling inhibition." Reactions Weekly &NA;, no. 1102 (May 2006): 4. http://dx.doi.org/10.2165/00128415-200611020-00011.
Full textOʼDonovan, David A., Giorgio C. La Scala, Iona Leong, Maria Mendes, Marianne Rogers, Kenneth H. Pritzker, Ivan Yeung, Cho Y. Pang, Peter C. Neligan, and Christopher R. Forrest. "Radiation-Induced Craniofacial Bone Growth Inhibition." Plastic and Reconstructive Surgery 129, no. 4 (April 2012): 636e—645e. http://dx.doi.org/10.1097/prs.0b013e31824421b6.
Full textSeiffert, Martina. "Checkpoint inhibition in the bone marrow." Nature Biomedical Engineering 2, no. 11 (November 2018): 793–94. http://dx.doi.org/10.1038/s41551-018-0319-6.
Full textVallet, Soni a., Nileshwari Vaghela, Mariateresa Fulciniti, Petter Veiby, Teru Hideshima, Samantha Pozzi, Loredana Santo, et al. "CCR1 Inhibition Targets Osteoclast-Myeloma Adhesion and Exerts in Vivo Anti-Osteoclast Activity." Blood 112, no. 11 (November 16, 2008): 2757. http://dx.doi.org/10.1182/blood.v112.11.2757.2757.
Full textYaccoby, Shmuel, Wen Ling, Fenghuang Zhan, Ronald Walker, Bart Barlogie, and John D. Shaughnessy. "Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo." Blood 109, no. 5 (October 26, 2006): 2106–11. http://dx.doi.org/10.1182/blood-2006-09-047712.
Full textWeaver, Samantha R., Hannah P. Fricke, Cynthia Xie, Robert J. Aiello, Julia F. Charles, and Laura L. Hernandez. "Peripartum dietary supplementation of a small-molecule inhibitor of tryptophan hydroxylase 1 compromises infant, but not maternal, bone." American Journal of Physiology-Endocrinology and Metabolism 315, no. 6 (December 1, 2018): E1133—E1142. http://dx.doi.org/10.1152/ajpendo.00198.2018.
Full textTerpos, Evangelos, Orhan Sezer, Peter Croucher, and Meletios-Athanassios Dimopoulos. "Myeloma bone disease and proteasome inhibition therapies." Blood 110, no. 4 (August 15, 2007): 1098–104. http://dx.doi.org/10.1182/blood-2007-03-067710.
Full textKomatsu, Koichiro, Akemi Shimada, Tatsuya Shibata, Satoshi Wada, Hisashi Ideno, Kazuhisa Nakashima, Norio Amizuka, Masaki Noda, and Akira Nifuji. "Alendronate promotes bone formation by inhibiting protein prenylation in osteoblasts in rat tooth replantation model." Journal of Endocrinology 219, no. 2 (November 2013): 145–58. http://dx.doi.org/10.1530/joe-13-0040.
Full textTeramachi, Jumpei, Masahiro Hiasa, Asuka Oda, Hirofumi Tenshin, Ryota Amachi, Takeshi Harada, Derek Hanson, et al. "Pim Inhibition Suppresses Osteoclastogenesis and Tumor Growth in Myeloma." Blood 126, no. 23 (December 3, 2015): 4203. http://dx.doi.org/10.1182/blood.v126.23.4203.4203.
Full textLee, Yongjin, Vipada Kantayos, Jin-Suk Kim, Eui-Shik Rha, Young-Jin Son, and So-Hyeon Baek. "Inhibitory Effects of Protopanaxadiol-Producing Transgenic Rice Seed Extracts on RANKL-Induced Osteoclast Differentiation." Life 12, no. 11 (November 14, 2022): 1886. http://dx.doi.org/10.3390/life12111886.
Full textFeng, Rentian, Xiangao Huang, G. David Roodman, Selina Chen-Kiang, and Suzanne Lentzsch. "Inhibition of Cdk4/6 by PD 0332991 Results in Abrogation of Osteoclast Formation." Blood 112, no. 11 (November 16, 2008): 3676. http://dx.doi.org/10.1182/blood.v112.11.3676.3676.
Full textZhao, Ming, Seon-Yle Ko, Jin-Hua Liu, Di Chen, Jianghong Zhang, Baolin Wang, Stephen E. Harris, Babatunde O. Oyajobi, and Gregory R. Mundy. "Inhibition of Microtubule Assembly in Osteoblasts Stimulates Bone Morphogenetic Protein 2 Expression and Bone Formation through Transcription Factor Gli2." Molecular and Cellular Biology 29, no. 5 (December 22, 2008): 1291–305. http://dx.doi.org/10.1128/mcb.01566-08.
Full textGebru, Yoseph, Teng-Yue Diao, Hai Pan, Emmanuel Mukwaya, and Yan Zhang. "Potential of RAS Inhibition to Improve Metabolic Bone Disorders." BioMed Research International 2013 (2013): 1–6. http://dx.doi.org/10.1155/2013/932691.
Full textKnowles. "The Adenosine A2B Receptor Drives Osteoclast-Mediated Bone Resorption in Hypoxic Microenvironments." Cells 8, no. 6 (June 21, 2019): 624. http://dx.doi.org/10.3390/cells8060624.
Full textDayyani, Farshid, Nila Parikh, Jian H. Song, John C. Araujo, Joan M. Carboni, Marco M. Gottardis, Geralyn C. Trudel, Christopher Logothetis, and Gary E. Gallick. "Inhibition of Src and insulin/insulin-like growth factor-1 receptor (IR/IGF-1R) on tumors and bone turnover in prostate cancer (PCa) models in vivo compared with inhibition of either kinase alone." Journal of Clinical Oncology 30, no. 5_suppl (February 10, 2012): 61. http://dx.doi.org/10.1200/jco.2012.30.5_suppl.61.
Full textKim, Tae-Ho, Eui Kyun Park, Man-Il Huh, Hong Kyun Kim, Shin-Yoon Kim, and Sang-Han Lee. "Rhus javanicaGall Extract Inhibits the Differentiation of Bone Marrow-Derived Osteoclasts and Ovariectomy-Induced Bone Loss." Evidence-Based Complementary and Alternative Medicine 2016 (2016): 1–7. http://dx.doi.org/10.1155/2016/3284704.
Full textLung, Hsuan, Tania Moody, Kelly Wentworth, Misun Kang, Sunita Ho, and Edward Hsiao. "Global Wnt Inhibition With a Porcupine Inhibitor Decreases Established Trabecular Bone in a Mouse Model of Fibrous Dysplasia." Journal of the Endocrine Society 5, Supplement_1 (May 1, 2021): A234. http://dx.doi.org/10.1210/jendso/bvab048.475.
Full textMuñoz-Garcia, Javier, Jorge William Vargas-Franco, Bénédicte Brounais-Le Royer, Denis Cochonneau, Jérôme Amiaud, Marie-Françoise Heymann, Dominique Heymann, and Frédéric Lézot. "Inhibiting Endothelin Receptors with Macitentan Strengthens the Bone Protective Action of RANKL Inhibition and Reduces Metastatic Dissemination in Osteosarcoma." Cancers 14, no. 7 (March 30, 2022): 1765. http://dx.doi.org/10.3390/cancers14071765.
Full textLin, Neng-Yu, Chih-Wei Chen, Rosebeth Kagwiria, Ruifang Liang, Christian Beyer, Alfiya Distler, Julia Luther, Klaus Engelke, Georg Schett, and Jörg HW Distler. "Inactivation of autophagy ameliorates glucocorticoid-induced and ovariectomy-induced bone loss." Annals of the Rheumatic Diseases 75, no. 6 (June 25, 2015): 1203–10. http://dx.doi.org/10.1136/annrheumdis-2015-207240.
Full textZang, Y., J. H. Song, S. H. Oh, J. W. Kim, M. N. Lee, X. Piao, J. W. Yang, et al. "Targeting NLRP3 Inflammasome Reduces Age-Related Experimental Alveolar Bone Loss." Journal of Dental Research 99, no. 11 (June 12, 2020): 1287–95. http://dx.doi.org/10.1177/0022034520933533.
Full textLillard, James, Rajesh Singh, Praveen Sharma, and Shailesh Singh. "CXCL13 inhibition prevents bone metastasis in hormone-refractory prostate cancer (133.8)." Journal of Immunology 184, no. 1_Supplement (April 1, 2010): 133.8. http://dx.doi.org/10.4049/jimmunol.184.supp.133.8.
Full textVanderkerken, Karin, Satya Medicherla, Les Coulton, Benjamin Van Camp, Andy Protter, Linda Higgins, Eline Menu, and Peter Croucher. "Inhibition of p38α MAPK Reduces Tumor Burden, Prevents the Development of Myeloma Bone Disease, and Increases Survival in the 5T2 and 5T33 Murine Models of Myeloma." Blood 108, no. 11 (November 16, 2006): 3436. http://dx.doi.org/10.1182/blood.v108.11.3436.3436.
Full textZhang, Junhe, Licheng Zhang, Meng Xu, Lihai Zhang, Peifu Tang, and Chuanlu Jiang. "Murine RANK Protein’s Inhibition of Bone Resorption." Journal of Craniofacial Surgery 22, no. 6 (November 2011): 2084–89. http://dx.doi.org/10.1097/scs.0b013e3182326d99.
Full textWang, Chenchao, Bharti Bisht, Jia Shen, Soonchu Lee, Yulong Zhang, Hsin Chuan Pan, Justine Tanjaya, Emily A. Berthiaume, Andrew L. Da Lio, and Chia Soo. "PPARγ Inhibition Impairs BMP2-Mediated Bone Repair." Journal of the American College of Surgeons 225, no. 4 (October 2017): e37-e38. http://dx.doi.org/10.1016/j.jamcollsurg.2017.07.618.
Full textNassar, Carlos Augusto, Patrícia Oehlmeyer Nassar, Patrícia Maria Nassar, and Luis Carlos Spolidorio. "Selective cyclooxygenase-2 inhibition prevents bone resorption." Brazilian Oral Research 19, no. 1 (March 2005): 36–40. http://dx.doi.org/10.1590/s1806-83242005000100007.
Full textTajima, Kosuke, Hironari Takaishi, Jiro Takito, Takahide Tohmonda, Masaki Yoda, Norikazu Ota, Naoto Kosaki, et al. "Inhibition of STAT1 accelerates bone fracture healing." Journal of Orthopaedic Research 28, no. 7 (January 8, 2010): 937–41. http://dx.doi.org/10.1002/jor.21086.
Full textAdachi, K., R. A. Chole, and J. Yee. "Indomethacin Inhibition of Middle Ear Bone Resorption." Archives of Otolaryngology - Head and Neck Surgery 117, no. 3 (March 1, 1991): 267–69. http://dx.doi.org/10.1001/archotol.1991.01870150035002.
Full textHorowitz, Stephen M., Sheila A. Algan, and Marie A. Purdon. "Pharmacologic inhibition of particulate-induced bone resorption." Journal of Biomedical Materials Research 31, no. 1 (May 1996): 91–96. http://dx.doi.org/10.1002/(sici)1097-4636(199605)31:1<91::aid-jbm11>3.0.co;2-p.
Full textDudakovic, Amel, Rebekah M. Samsonraj, Christopher R. Paradise, Catalina Galeano-Garces, Merel O. Mol, Daniela Galeano-Garces, Pengfei Zan, et al. "Inhibition of the epigenetic suppressor EZH2 primes osteogenic differentiation mediated by BMP2." Journal of Biological Chemistry 295, no. 23 (April 24, 2020): 7877–93. http://dx.doi.org/10.1074/jbc.ra119.011685.
Full textGiuliani, Nicola, Vittorio Rizzoli, and G. David Roodman. "Multiple myeloma bone disease: pathophysiology of osteoblast inhibition." Blood 108, no. 13 (December 15, 2006): 3992–96. http://dx.doi.org/10.1182/blood-2006-05-026112.
Full textSasaki, T., N. S. Ramamurthy, and L. M. Golub. "Long-Term Therapy with a New Chemically Modified Tetracycline (CMT-8) Inhibits Bone Loss in Femurs of Ovariectomized Rats." Advances in Dental Research 12, no. 1 (November 1998): 76–81. http://dx.doi.org/10.1177/08959374980120012501.
Full textSun, Qi, Yuanzhen Zhang, Yilan Ding, Wenqing Xie, Hengzhen Li, Shaohua Li, Yusheng Li, and Ming Cai. "Inhibition of PGE2 in Subchondral Bone Attenuates Osteoarthritis." Cells 11, no. 17 (September 5, 2022): 2760. http://dx.doi.org/10.3390/cells11172760.
Full textYaccoby, Shmuel, Wen Ling, Rinku Saha, Fenghuang Zhan, Ron Walker, Guido Tricot, Bart Barlogie, and John D. Shaughnessy. "Inhibition of DKK1 Activity Is Associated with Increased Osteoblast Numbers and Bone Formation, Reduced Osteoclast Activity and Inhibition of Tumor Growth in the SCID-rab Model for Primary Myeloma." Blood 106, no. 11 (November 16, 2005): 638. http://dx.doi.org/10.1182/blood.v106.11.638.638.
Full textLundy, M. W., K. H. Lau, H. C. Blair, and D. J. Baylink. "Chick osteoblasts contain fluoride-sensitive acid phosphatase activity." Journal of Histochemistry & Cytochemistry 36, no. 9 (September 1988): 1175–80. http://dx.doi.org/10.1177/36.9.3403968.
Full textHideshima, Teru, Pierfrancesco Tassone, Dharminder Chauhan, Kenji Ishitsuka, Constantine Mitsiades, Noopur Raje, Shaji Kumar, et al. "Targeting IKK Inhibits Multiple Myeloma (MM) Cell Growth in the Bone Marrow Microenvironment." Blood 104, no. 11 (November 16, 2004): 2351. http://dx.doi.org/10.1182/blood.v104.11.2351.2351.
Full textKameda, Takashi, Hiroshi Mano, Tatsuhisa Yuasa, Yoshihisa Mori, Koshi Miyazawa, Miho Shiokawa, Yukiya Nakamaru, et al. "Estrogen Inhibits Bone Resorption by Directly Inducing Apoptosis of the Bone-resorbing Osteoclasts." Journal of Experimental Medicine 186, no. 4 (August 18, 1997): 489–95. http://dx.doi.org/10.1084/jem.186.4.489.
Full textSteinbicker, Andrea U., Chetana Sachidanandan, Ashley J. Vonner, Rushdia Z. Yusuf, Donna Y. Deng, Carol S. Lai, Kristen M. Rauwerdink, et al. "Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation." Blood 117, no. 18 (May 5, 2011): 4915–23. http://dx.doi.org/10.1182/blood-2010-10-313064.
Full text